Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474691 · ClinicalTrials.gov registry record · NA
staRt: Enhancing Speech Treatment With Smartphone-delivered Biofeedback
A NA study, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04474691 is a NA study that has completed, run by New York University. The registered enrollment target is 15 participants.
The verdict
NCT04474691, a NA study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Previous research suggests that biofeedback can outperform traditional interventions for RSE, but no controlled studies have tested this hypothesis in the context of app-delivered biofeedback. The objective of this aim is to use the staRt app to test our working hypothesis that speakers will make larger gains in /r/ accuracy when app-based treatment incorporates biofeedback, compared to a non-biofeedback condition. With a network of cooperating SLPs, this project will recruit 15 children with /r/ misarticulation to receive 8 weeks of intervention using staRt. Individual sessions will be randomly assigned to include or exclude the visual biofeedback display. Randomization tests will be used to evaluate, for each individual, whether larger increments of change are associated with biofeedback and non-biofeedback sessions.
Interventions
- BEHAVIORAL Visual-acoustic biofeedback
- BEHAVIORAL Traditional articulation treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-04-04 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04474691
The ClinicalTrials.gov registry entry for NCT04474691 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Visual-acoustic biofeedback is the first listed.
NCT04474691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04474691 about?
NCT04474691 is a clinical study titled "staRt: Enhancing Speech Treatment With Smartphone-delivered Biofeedback". Previous research suggests that biofeedback can outperform traditional interventions for RSE, but no controlled studies have tested this hypothesis in the context of app-delivered biofeedback. The objective of this aim is to use the staRt app to test our working hypothesis that speakers will make la...
What is the current status of trial NCT04474691?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-04-04. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT04474691?
The interventions under investigation include: Visual-acoustic biofeedback (BEHAVIORAL), Traditional articulation treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04474691?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.